TycelJovellePhillipsMD

PubMed

• Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?
  Tycel J. Phillips, Jean-Marie Michot, Vincent Ribrag> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Sep 18
• Burkitt Lymphoma in the Modern Era: Real World Outcomes and Prognostication Across 30 US Cancer Centers.
  Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Daniel Rector, Suchitra Sundaram, Nishitha Reddy, Yong Lin, ...> ;Blood. 2020 Jul 14
• Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas
  Taylor M Weis, Bernard L. Marini, Victoria R. Nachar, Anna Brown, Tycel J. Phillips, Julia Brown, Ryan A. Wilcox, Mark S. Kaminski, Sumana Devata, Anthony J. Perissinotti> ;Leukemia & Lymphoma. 2020 Apr 15
• Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.
  Jennifer Girard, John C. Reneau, Sumana Devata, Ryan A. Wilcox, Mark S. Kaminski, Jessica Mercer, Shannon A. Carty, Tycel J. Phillips> ;OncoTargets and Therapy. 2019 Sep 30
• Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
  Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro, Sumana Devata, Scott D. Gitlin, Mark S. Kaminski, Alice M. Cusick, Tycel J. Ph...> ;The Lancet Haematology. 2019 Sep 16
• Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.
  Marcus Geer, Emily Roberts, Maryann Shango, Brian G. Till, Stephen D. Smith, Hashim Abbas, Brian T. Hill, Jason B. Kaplan, Paul M. Barr, Paolo Caimi, Deborah M. Stephe...> ;British Journal of Haematology. 2019 Jul 1
• Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
  Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S. Wertheim, William Jeffery Edenfield, Paolo F Caimi, Martin Gutierrez, Luke P. Akard, Ca...> ;Blood. 2019 Apr 18
• A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
  Tycel J. Phillips, Paul M. Barr, Steven I. Park, Kathryn S. Kolibaba, Paolo F Caimi, Saurabh Chhabra, Edwin C. Kingsley, Thomas E. Boyd, Robert Chen, Anne Sophie Carre...> ;Investigational New Drugs. 2019 Apr 1
• Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
  Tycel J. Phillips, Andres Forero-Torres, Taimur Sher, Catherine Diefenbach, Patrick B. Johnston, Moshe Talpaz, Jennifer Pulini, Li Zhou, Peggy Scherle, Xuejun Chen, Pa...> ;Blood. 2018 Jul 19
• Pegasparaginase silent inactivation during therapy for NK/T cell lymphoma
  Deeter R. Neumann, Bernard L. Marini, Tycel J. Phillips, Ryan A. Wilcox, Tera Mayer, Anna Brown, Anthony J. Perissinotti> ;Leukemia & Lymphoma. 2018 Jul 1
• Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL).
  Janie Y. Zhang, Robert Briski, Sumana Devata, Mark S. Kaminski, Tycel J. Phillips, Tera Mayer, Nathanael G. Bailey, Ryan A. Wilcox> ;American Journal of Hematology. 2018 Mar 1
• Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
  Carlos Murga-Zamalloa, Avery Polk, Walter Hanel, Pinki Chowdhury, Noah A. Brown, Alexandra C. Hristov, Nathanael G. Bailey, Tianjiao Wang, Tycel J. Phillips, Sumana De...> ;Oncotarget. 2017 Dec 6
• A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
  Philip S. Boonstra, Avery Polk, Noah A. Brown, Alexandra C. Hristov, Nathanael G. Bailey, Mark S. Kaminski, Tycel J. Phillips, Sumana Devata, Tera Mayer, Ryan A. Wilcox> ;American Journal of Hematology. 2017 Dec 1
• RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
  Robert Chen, Hongli Li, Steven H. Bernstein, Samir B. Kahwash, Lisa M. Rimsza, Stephen J. Forman, Louis S. Constine, Thomas C. Shea, Amanda F. Cashen, Kristie A. Blum,...> ;British Journal of Haematology. 2017 Mar 1
• Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.
  Tycel J. Phillips, Sumana Devata, Ryan A. Wilcox> ;Journal for ImmunoTherapy of Cancer. 2016 Dec 20
• Postibrutinib outcomes in patients with mantle cell lymphoma.
  Peter Martin, Kami J. Maddocks, John P. Leonard, Jia Ruan, Andre Goy, Nina D. Wagner-Johnston, Simon Rule, Ranjana H. Advani, David J. Iberri, Tycel J. Phillips, Steph...> ;Blood. 2016 Mar 24
• Cutaneous Complications in Hematopoietic Cell Transplant Recipients: Impact of Biopsy on Patient Management
  Oana Paun, Tycel J. Phillips, Pingfu Fu, Roberto A. Novoa, Kord Honda, Kurt Q. Lu, Hillard M. Lazarus> ;Biology of Blood and Marrow Transplantation. 2013 Aug 1
• Join now to see all

Abstracts/Posters

• Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-HodgkinÍs Lymphoma and C...
  Tycel J. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
  Tycel J. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax i...
  Tycel J. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Cen... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Updated Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-) in Patients with Mantle Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all